We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Sperm DNA Test Diagnoses Idiopathic Infertility

By LabMedica International staff writers
Posted on 27 Nov 2012
A male fertility test has been utilized to discover the cause of unexplained infertility for many couples trying to have a baby. More...


Around 80% of couples who are diagnosed with unexplained or idiopathic infertility have a known cause called high sperm DNA damage and the test can help these couples understand better treatment options, which will keep them from wasting their money, time, and emotions.

Scientists at Queen's University Belfast (UK) studied over 500 couples, and utilized the male fertility test in the most recent round of trials conducted by the well-known male fertility experts at the university. Almost one third of couples had no obvious cause for infertility and these couples were given the diagnosis of “unexplained fertility.” These couples often invest a lot of time and money in fertility treatments like intrauterine insemination (IUI) which is unlikely to be successful. The study explained the cause of infertility for many of those couples.

The other significant finding revealed by the study is that it is the first to present evidence suggesting that the likelihood of conceiving after in vitro fertilization (IVF) is linked to the amount of damaged DNA a man's sperm contains. A small amount of damage such as less than 15% of sperm is considered normal. However, if the damage reaches more than 25% of sperm, the chances of having a baby are lowered, even if the couple is going through fertility treatment.

The male fertility test used in the study is called SpermComet (Lewis Fertility Testing Ltd, Belfast, UK). The SpermComet test is so called because it looks just like a comet in the skies. The head of the “comet” is undamaged DNA and the tail is damaged DNA. From the tail of the comet, the exact amount of damaged DNA in each individual sperm can be measured.

Sheena E.M. Lewis, PhD, a professor at Queen's University, said, "We have developed the SpermComet, which is a unique test for male infertility that measures damaged DNA in individual sperm providing all couples with specific information about the causes and extent of their infertility. This test can predict the success of infertility treatments and fast-track couples to the treatment most likely to succeed, leading to reduced waiting times and improved chances of success."

Related Links:

Queen's University Belfast
Lewis Fertility Testing Ltd.



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
Gold Member
Platelet Function Analyzer
PL-12
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.